Answers are grounded in this paper and cite their sources.
PURPOSE: Recent evidence suggests cyclin E1 (CCNE1) amplification as a potential novel therapeutic target. The clinical significance of CCNE1 amplification in breast cancer remains poorly defined. This study explores the clinicogenomic characteristics of CCNE1-amplified breast cancer. EXPERIMENTAL DESIGN: We analyzed genomic and clinical data from patients included in the MSK Breast Translational database who underwent targeted sequencing between January 2014 and October 2025. Allele-specific copy number, including CCNE1 amplification, was assessed by FACETS. RESULTS: Out of 6,318 breast cancers, 251 (4.0%) had CCNE1 amplification. The prevalence of CCNE1 amplification was lower in HR+/HER2- (2.1%) compared to HER2+ (6.7%) and triple-negative breast cancers (8.7%, P<2.2x10-16). CCNE1 amplification was associated with aggressive clinicopathological features across all receptor subtypes. HR+/HER2- tumors harboring CCNE1 amplification had higher tumor grade (77.1% vs 57.1%, P=8.3x10-04), lack of progesterone receptor expression (27.0% vs 15.2%, P=8.8x10-03) and a higher prevalence of estrogen-receptor low expression (ER ≤10%, 25.4% vs 6.5%, P=8.4x10-07). CCNE1-amplified breast cancers were associated with TP53 alterations, high fraction of genome altered, and whole genome doubling events, reflecting marked chromosomal instability. CCNE1 amplification was associated with significantly shorter PFS on first-line THP in HER2+ subtype (8.4 vs 18.0 months, HR 2.33, 95%CI 1.31-4.12, P=3.8×10⁻³), and non-significant trends toward shorter PFS in HR+/HER2- (HR 1.49, 95%CI 0.86-2.58, P=0.16) and triple-negative cancers (HR 1.43, 95%CI 0.95-2.15, P=0.084). CONCLUSIONS: CCNE1 amplification defines a subset of breast cancer characterized by high genomic instability and poor clinical outcomes, supporting its role as a potential biomarker for novel therapeutic strategies in this clinical context.
No takes yet. Share an insight, caveat, or question.
Marra et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: